anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

List

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,471
Current window 85,531-85,560
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all
18 30 60

Component

85,531-85,560 of 110,471

filter-aware
07
Includes specific commentary on North America and International revenue drivers, as well as operating income growth factors.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Loop · Logic Chain1 hit
10
The slide uses a numbered list format with circular imagery to represent each pillar.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
11
The slide includes a table of financial figures and a bulleted list of liquidity/debt highlights.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Beat · VisualizationLoop · Logic Chain1 hit
13
The chart is a classic cash flow bridge/waterfall.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Beat · VisualizationLoop · Logic Chain1 hit
05
The slide highlights a total revenue of 56.5 billion euros.LVMH | Results Presentation Deck | 28 slides · LVMH
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
09
The chart uses a standard waterfall bridge to explain the variance between two periods.LVMH | Results Presentation Deck | 28 slides · LVMH
Conference presentation Investor relations Loop · Logic Chain1 hit
16
LVMH | Results Presentation Deck | 28 slidesLVMH | Results Presentation Deck | 28 slides · LVMH
Conference presentation Investor relations Loop · Logic Chain1 hit
03
Includes stock market data as of September 30, 2022.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Attention1 hit
05
The chart highlights the 'Pandemic' period as a shaded region.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Attention1 hit
06
The chart is an area chart showing the spread between NII/Avg Earning Assets and NIE/Avg Earning Assets, labeled as NIM.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
07
MainStreet Bancshares | Results Presentation Deck | 31 slidesMainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
25
MainStreet Bancshares | Results Presentation Deck | 31 slidesMainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
04
The slide illustrates the self-assembly of Phosphatidylserine (PS) and Calcium ions into a cochleate structure.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
15
The slide uses a process-flow diagram to present five key clinical findings.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
22
Includes MIC comparison, tissue fungal burden (lung/brain), and survival curves.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
The slide uses a map of the US to anchor the revenue projection and a list of four comparable deals to establish market precedent.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Market Sizing1 hit
26
Data presented as three distinct charts: line graph for weight, dot plot for congestion, and dot plot for viral titers.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
30
Uses checkmarks for completed items and circular arrows for upcoming/potential items.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
06
The chart compares quarterly container volumes between 2021 and 2022.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
07
The chart shows a 15.1% decrease in Q3 2022 volume compared to Q3 2021.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
08
The chart compares quarterly container volumes between 2021 and 2022.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
09
Includes a footnote regarding 4Q21 volume benefit from a 53rd week.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
10
The chart shows quarterly operating income for 2021 and 2022, with Q3 2022 highlighted as a range.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
04
The slide details a strategic partnership involving equity investment and asset licensing.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
10
Study methodology involves 10-week treatment on high fat/fructose/CHO diet.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
11
Study design timeline included; statistical significance noted for treatment groups.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
15
The slide uses a hub-and-spoke diagram to illustrate the systemic effects of oxyntomodulin.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
Data from preclinical study in HF-DIO mice.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
18
Study uses male DIO-NASH mice with 30-week GAND feeding and 9-week treatment regimen.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
27
NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slidesNeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit